# Cardiac amyloidosis recognition and diagnosis for GPs

Page: https://stenobird.com/podcast/the-good-gp-1116813/cardiac-amyloidosis-recognition-and-diagnosis-for-gps
Text version: https://stenobird.com/podcast/the-good-gp-1116813/cardiac-amyloidosis-recognition-and-diagnosis-for-gps.md
Podcast: [The Good GP](https://stenobird.com/podcast/the-good-gp-1116813)
Published: 2026-04-27T17:30:00+00:00
Episode link: https://thegoodgp.com.au/episode/cardiac-amyloidosis-recognition-and-diagnosis-for-gps
Audio file: https://pscrb.fm/rss/p/episodes.captivate.fm/episode/655671ad-90fd-461e-9aac-39c513ba8a31.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-good-gp-1116813/episodes/cardiac-amyloidosis-recognition-and-diagnosis-for-gps
Duration seconds: 1748

## Resource

In this episode, host Dr Krystyna De Lange speaks with Sydney-based cardiologist Dr Natasha Gorrie from St Vincent's Hospital and the Victor Chang Cardiac Research Institute. They discuss cardiac amyloidosis, an under-recognised cause of heart failure in older adults and a condition with evolving diagnostic and treatment approaches. Dr Natasha Gorrie outlines the basics of amyloidosis, emphasising that it is an umbrella term for disorders characterised by the deposition of abnormal protein fibrils in tissues and organs. Key Points: Understanding Amyloidosis: The pathology and range of organ involvement; why diagnosis depends on identifying the causative protein. Epidemiology and Prevalence: Recent recognition that transthyretin-related amyloidosis (ATTR) is more common than previously thought, with prevalence as high as one in six in certain heart failure populations. Key Clinical Clues: Red flag features in patients (particularly those over the age of 65), including heart failure with preserved ejection fraction, left ventricular wall thickening, atrial fibrillation, aortic stenosis, carpal tunnel syndrome, and unexplained changes in blood pressure medication requirements. Diagnostic Pathway: The importance of timely suspicion, appropriate specialist referral, and the role of the monoclonal screen (serum and urine electrophoresis and serum free light chains) to rule out AL (light chain) amyloidosis. The role of bone scintigraphy and when tissue biopsy is indicated. Therapeutic Options: Overview of disease-modifying treatments available for different amyloid subtypes, including the PBS-approved medication tafamidis for ATTR cardiac amyloidosis. The GP’s Role: GPs are essential for early suspicion, referral, initiation of screening tests, and, following diagnosis, ongoi…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-good-gp-1116813/episodes/cardiac-amyloidosis-recognition-and-diagnosis-for-gps/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-good-gp-1116813/cardiac-amyloidosis-recognition-and-diagnosis-for-gps.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.